Evidence map›Paper›PMID 31955603›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2020

Low reactivity of tumor MUC1-binding natural anti-α-galactoside antibody is a risk factor for breast cancer.

Jessy John, Kurian Cherian, Thomas Abraham, Padinjaradath S Appukuttan

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jessy JohnDepartment of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 695 011, India.
Kurian CherianDivision of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram 695 011, India.
Thomas AbrahamDivision of Clinical Laboratory Services, Regional Cancer Centre, Thiruvananthapuram 695 011, India.
Padinjaradath S AppukuttanDepartment of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 695 011, India.ORCID 0000-0003-0926-3491
Regional Cancer Center, Thiruvananthapuram · INSree Chitra Thirunal Institute for Medical Sciences and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntibodiesBreast NeoplasmsGalactosidesHumansMucin-1PhenotypeRisk FactorsAntibodiesGalactosidesMUC1 protein, humanMucin-1affinity maturationanti-α-galactoside antibodyBreast cancerlipoprotein(a)serine- and threonine-rich peptide sequencetumor-associated MUC1

Identifiers

PMID31955603
PMCPMC7045334
OpenAlexW3000353531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.